SMTL ID : 9bdo.3 (2 other biounits)

Crystal structure of anti-abTCR NANOBODY VHH

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 3 residues within 4Å: Chain A: R.19, K.75, Y.79 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.19, A:K.75, A:Y.79 Water bridges: A:R.19, A:K.75 GOL.3: 2 residues within 4Å: Chain A: Y.94, Q.109 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.94, A:Y.94

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 7 residues within 4Å: Chain A: Y.34, R.71, D.72, E.73, N.76, T.77, V.78 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.72 Salt bridges: A:R.71 ACT.4: 6 residues within 4Å: Chain A: D.61, S.62, A.63, K.64, R.66, R.86 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:R.66 Hydrogen bonds: A:K.64, A:K.64 Salt bridges: A:R.86

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.5: 2 residues within 4Å: Chain A: H.29, K.30 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:H.29, A:K.30 Salt bridges: A:K.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Meoni, P. et al., Identification and non-clinical characterization of SAR444200, a novel anti-GPC3 NANOBODY T cell engager, for the treatment of GPC3+ solid tumors. To Be Published

Release Date

2025-04-16

Peptides

TCE01 NANOBODY VHH: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

TCE01 NANOBODY VHH

Related Entries With Identical Sequence